Overview

Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts

Status:
Withdrawn
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
This is a randomised, controlled, open-label study of a single intralesional administration of I-040302 or a single bone marrow aspirate or a single steroid injection (methylprednisolone). Subjects will undergo screening with X-ray and magnetic resonance imaging (MRI) in the diagnosis of a solitary bone cyst.
Phase:
Phase 2
Details
Lead Sponsor:
Kuros Biosurgery AG